112 related articles for article (PubMed ID: 32652401)
21. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
22. BCS class II drug loaded protein nanoparticles with enhanced oral bioavailability:
Kasekar NM; Singh S; Jadhav KR; Kadam VJ
Drug Dev Ind Pharm; 2020 Jun; 46(6):955-962. PubMed ID: 32362144
[TBL] [Abstract][Full Text] [Related]
23. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
24. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
Zoghbi A; Geng T; Wang B
AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
[TBL] [Abstract][Full Text] [Related]
25. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
26. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
27. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
Sahu BP; Das MK
Acta Pol Pharm; 2014; 71(1):129-37. PubMed ID: 24779201
[TBL] [Abstract][Full Text] [Related]
28. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.
Zhang Y; Luo R; Chen Y; Ke X; Hu D; Han M
AAPS PharmSciTech; 2014 Jun; 15(3):560-8. PubMed ID: 24570374
[TBL] [Abstract][Full Text] [Related]
29. Bioavailability Enhancement of Astilbin in Rats through Zein-Caseinate Nanoparticles.
Zheng D; Zhang QF
J Agric Food Chem; 2019 May; 67(20):5746-5753. PubMed ID: 31045359
[TBL] [Abstract][Full Text] [Related]
30. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: formulation, characterization, and in vivo pharmacokinetics.
Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
Eur J Pharm Biopharm; 2013 Aug; 84(3):487-96. PubMed ID: 23403015
[TBL] [Abstract][Full Text] [Related]
31. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics.
Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
Int J Nanomedicine; 2013; 8():1721-32. PubMed ID: 23658490
[TBL] [Abstract][Full Text] [Related]
32. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of modified gum karaya as a carrier for improving the oral bioavailability of a poorly water-soluble drug, nimodipine.
Murali Mohan Babu GV; Kumar NR; Sankar KH; Ram BJ; Kumar NK; Murthy KV
AAPS PharmSciTech; 2002; 3(2):E12. PubMed ID: 12916949
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
35. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
[TBL] [Abstract][Full Text] [Related]
36. l-Arginine/l-lysine functionalized chitosan-casein core-shell and pH-responsive nanoparticles: fabrication, characterization and bioavailability enhancement of hydrophobic and hydrophilic bioactive compounds.
Du Z; Liu J; Zhang H; Chen Y; Wu X; Zhang Y; Li X; Zhang T; Xiao H; Liu B
Food Funct; 2020 May; 11(5):4638-4647. PubMed ID: 32400776
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles.
Shaker MA; Elbadawy HM; Al Thagfan SS; Shaker MA
Int J Pharm; 2021 Jan; 592():120077. PubMed ID: 33246047
[TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
40. Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment.
Tang J; Xu N; Ji H; Liu H; Wang Z; Wu L
Int J Nanomedicine; 2011; 6():2429-35. PubMed ID: 22072878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
